Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Use of Bioscaffolds in Conjunction With Negative Pressure Therapy: A Prospective Randomized Double-Blinded Trial

This study has been withdrawn prior to enrollment.
Sponsor:
Collaborator:
Beth Israel Deaconess Medical Center
Information provided by (Responsible Party):
Integra LifeSciences Corporation
ClinicalTrials.gov Identifier:
NCT01228500
First received: October 25, 2010
Last updated: May 15, 2016
Last verified: May 2016
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: No date given
  Primary Completion Date: January 2013 (Final data collection date for primary outcome measure)